Anti-C1q antibodies in systemic lupus erythematosus are a biological marker of the activity of nephritis, a predictor for its development and a poor life prognosis
-
Saved in:
| Main Authors: | Mariya Eduardovna Tsanyan, E N Aleksandrova, S K Solovyev, E L Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2013-02-01
|
| Series: | Научно-практическая ревматология |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1115 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYTOKINE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Maria Eduardovna Tsanyan, et al.
Published: (2013-12-01) -
USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01) -
Anti-B cell therapy in patients with systemic lupus erythematosus
by: M. E. Tsanyan, et al.
Published: (2018-01-01) -
PROSPECTS FOR PHARMACOTHERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. L. Nasonov, et al.
Published: (2014-06-01) -
Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus
by: Wei-Chen Kao, et al.
Published: (2025-04-01)